Posted in | News | Silver | Uranium

Rockgate Capital Reports Assay Results from Falea Project

Rockgate Capital Corp. (TSX:RGT) has announced assay results from five diamond drill holes completed on the 084 Trend, North Zone Area at Rockgate's 100% owned Falea Project.

084 Trend

  • Mineralization is hosted in competent, flat-lying sandstones near the unconformity.
  • The continuing confirmation of the tabular and uniform nature of the orebody indicates that a room and pillar mining operation should be feasible.
  • 25 x 25 metre grid drilling confirms consistent high grade uranium mineralization.
  • Higher grade mineralization along north-west trend.

General Discussion

  • Additional high-grade uranium-silver mineralization may be associated with similar north-west trends already identified in the North Zone.
  • The Falea Sedimentary Basin appears to be similar in age and geological setting to the Athabasca Basin in Canada. The Falea Basin hosts high-grade uranium mineralization similar to that of the Athabasca Basin.
  • To date, only 5-6 percent of area hosting down-hole radiometric anomalies has been drill tested.

Mr. Lorne Warner, P. Geo, Director and VP Exploration, is the Qualified Person for the Company under NI 43-101. All core samples are cut in half on site and sent to ALS-Chemex in Bamako for direct shipment to ALS-Chemex in Johannesburg, South Africa, for ICP-MS and XRF analysis. The company inserts a standard, blank and requests a duplicate sample be run in every batch of 20 samples. In addition, the lab inserts in-house blanks, standards, and duplicates with each shipment. Data that falls outside the control limits are checked and repeated as necessary.

Source:

Rockgate Capital Corp.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.